Familial hypercholesterolemia: Genetic diagnosis and cascade testing using NGS
At present, FH is greatly underdiagnosed, and most cases are not discovered until the affected individual suffers his or her first cardiovascular event.
This paper by Peter Benedek and Kristina Duvefelt, Karolinska University Hospital, Stockholm, Sweden, introduces the clinical diagnosis, indicators and symptoms, and treatment of FH, before examining the background and current status of genetic testing for FH, and new best practices enabled by Next Generation Sequencing.
- Clinical diagnosis, indicators and symptoms, and treatment of FH.
- Background and current status of genetic testing for FH.
- New best practices enabled by Next Generation Sequencing.
Get access to the paper by filling out the form below
Related content
View allDevyser partners with Hamilton to automate laboratory NGS workflows
Read More
Devyser receives MDSAP certification for Brazil
Read More
Devyser publishes annual report for 2023
Devyser´s annual report 2023 has today been published on the company´s website. The report is...
Read More